Lumos Pharma Analyst Ratings
BenzingaMar 20 12:26 ET
Lumos Pharma's LUM-201 Receives 'Buy' Rating on Strong Market Position and Promising Trial Outcomes
TipRanksMar 20 11:45 ET
Lumos Pharma Analyst Ratings
BenzingaMar 8 06:50 ET
Analysts Are Bullish on Top Healthcare Stocks: Lumos Pharma (LUMO), Arcturus Therapeutics (ARCT)
TipRanksMar 8 06:30 ET
Lumos Pharma Analyst Ratings
BenzingaDec 11, 2023 10:19 ET
Oppenheimer Trims Lumos Pharma Price Target to $16 From $17, Maintains Outperform Rating
MT NewswiresDec 11, 2023 09:08 ET
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
BenzingaDec 7, 2023 06:43 ET
Lumos Pharma Analyst Ratings
BenzingaDec 7, 2023 06:42 ET
Analysts Are Bullish on Top Healthcare Stocks: Lumos Pharma (LUMO), Rhythm Pharmaceuticals (RYTM)
TipRanksNov 8, 2023 06:20 ET
Promising Results and Buy Rating for Lumos Pharma's Groundbreaking Growth Hormone Stimulant: LUM-201
TipRanksSep 26, 2023 10:46 ET
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
BenzingaSep 6, 2023 06:30 ET
Lumos Pharma Analyst Ratings
BenzingaSep 6, 2023 06:29 ET
Analysts Offer Insights on Healthcare Companies: Acrivon Therapeutics, Inc. (ACRV), Insmed (INSM) and Lumos Pharma (LUMO)
TipRanksSep 6, 2023 06:20 ET
Cantor Fitzgerald Reiterates Overweight on Lumos Pharma, Maintains $10 Price Target
BenzingaAug 22, 2023 09:55 ET
Lumos Pharma Analyst Ratings
BenzingaAug 22, 2023 09:54 ET
Lumos Pharma Analyst Ratings
BenzingaAug 15, 2023 08:11 ET
Analysts Offer Insights on Healthcare Companies: REPRO-MED Systems (KRMD), Lumos Pharma (LUMO) and Curaleaf Holdings (OtherCURLF)
TipRanksAug 10, 2023 09:20 ET
Oppenheimer Adjusts Lumos Pharma Price Target to $17 From $18, Maintains Outperform Rating
MT NewswiresAug 10, 2023 09:04 ET
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
BenzingaAug 10, 2023 06:35 ET
Lumos Pharma Analyst Ratings
BenzingaAug 10, 2023 06:34 ET
No Data
No Data